C O M M E N T
HIF, stretching to get control of VEGF A B S T R A C T
Mechanical forces are key regulators of cell function, particularly of cells within the arterial wall that are exposed to the shear stress and pulsatile pressure of flowing blood. The finding by Chang and colleagues in this issue of Clinical Science that cell stretch can up-regulate the expression of hypoxia-inducible factor-1α and vascular endothelial growth factor, which is a key regulator of blood vessel remodelling, provides us with further insight into the mechanisms underlying remodelling at sites of occlusive disease within the cardiovascular system.
In the body, cells exist within a mechanically active environment due to events such as gross and fine motor activity, organ contraction and dilation, and the passage of fluids. Under standard culture conditions, however, cells are maintained within a static environment and so this important regulator of cell function is absent. Within blood vessels one of the most obvious sources of cellular mechanical strain is the flow of blood, which exerts a shear stress upon the vascular wall [1] . In addition, in larger arterial vessels the pulsatile pressure generated by the beating of the heart subjects the blood vessel wall to mechanical stretch and cellular compression. It is unclear what the mechanosensors are for these events, but studies have implicated stretch-sensitive ion channels, protein kinases associated with the cytoskeleton, integrin-cytoskeletal interactions, cytoskeletalnuclear interactions and oxidase systems capable of generating reactive oxygen species [2] . As the mechanical forces of stretch and shear are always present within blood vessels, they are understood to be key regulators of blood vessel wall modelling and mediator production [3] . Mechanical stretch has been particularly studied for its influence upon vascular smooth muscle function, as the layer of endothelial cells along the inside of blood vessels protect the smooth muscle from the direct shearing effects of the flowing blood, whereas the pulsing blood clearly stretches the entire vascular wall.
Studying the roles of mechanical forces in culture conditions is complex. For vascular cells, particularly endothelial cells, shear stress chambers have been widely used for investigations. The other mechanical forces of compression and stretch have been investigated rather less. One approach that has been used is to culture cells Key words: gene expression, hypoxia-inducible factor-1α (HIF-1α), mitogen-activated protein kinase (MAP kinase), smooth muscle cell, stretch.
on flexible-bottomed plates, which are then regularly stretched by the application of a vacuum to the underside of the plate [4] . This approach provides a model of cellular stretch, although, of course, not of compression, as the cells are pulled by vacuum rather than being pushed by pressure.
In this issue of Clinical Science, the study by Chang and co-workers [5] showed that when rat arterial smooth muscle cells are stretched under such conditions the expression of hypoxia-inducible factor-1 (HIF-1)α is markedly up-regulated. This is associated with an increase in the expression of vascular endothelial growth factor (VEGF), as VEGF is a target gene of HIF-1. Why is this interesting? HIF-1 is a DNA-binding complex which is now understood to be a key regulator of the expression of genes responding to changes in cellular oxygen tension [6] . HIF-1 activity depends on the amount of HIF-1α subunit, and it is this which is tightly regulated by the oxygen tension. HIF-1 has attracted particular interest as a regulator of tumour growth, due to its involvements in angiogenesis. With regard to mechanical influences, HIF-1 has been shown previously to be up-regulated in the heart by increases in ventricular wall tension, including that induced by an intraventricular balloon [7] . VEGF is best characterized as a potent mitogen within the vasculature, and so we could suppose that increased stretch of the blood vessel wall could up-regulate the expression of HIF-1, leadingto an increase in the expression of VEGF and so increased proliferation within the blood vessel wall. Could this explain the thickening seen with increases in blood pressure [8] and at sites of mechanical perturbation within the vasculature? If so, this would then suggest that this could well be a protective mechanism, i.e. thickening the blood vessel wall to cope with increased pressure, which could run unchecked following exposure to extreme forces, such as that caused by balloon angioplasty.
There are, however, some caveats that should be considered. What we must remember is that in these kinds of experiments the cells are going from a static environment to an active one. It is therefore important to note that these experiments test the responses of the cells to a dramatic change in environment; from being static to being mechanically deformed. For cells in the blood vessel wall being stretched is part of their normal environment. This may explain why a number of studies have shown various stress-related factors to be up-regulated following stretching of cells cultured in a previously static environment. However, the cells may well be responding to the change in their environment. Over the next 24 to 48 h of the experiments, the expression of these factors may decline as the stretching environment becomes the cells' new normalcy. At these later time points, cells may more accurately represent those in vivo, which exist in a normally mechanically active environment and under physiological conditions do not express many of these stress-related factors. Of course, the mechanical stress experiments do help us understand how abnormal changes in the mechanical environment, such as balloon angioplasty, increases in blood pressure or changes in flow due to occlusive diseases, could lead to changes in the expression of HIF-1 and, importantly for blood vessel remodelling, of VEGF. Characterization of the mechanosensors regulating this could provide novel interventions to inhibit the overproduction of factors involved in remodelling at sites of occlusive disease within the cardiovascular system. 
